Symbol
RVNC
Investment type
Equity / Common Stock, par value $0.001 per share
Latest Disclosed Shares Owned
1,611,787 shares
Security Ownership %
1.5%
Shares, Excluding Options vs Price
Value, Excluding Options

Patrick Lee, MD ownership in Revance Therapeutics, Inc. Common Stock, par value $0.001 per share (RVNC)

13 Feb 2025 - Patrick Lee, MD has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,611,787 shares of Revance Therapeutics, Inc. Common Stock, par value $0.001 per share (RVNC). This represents 1.5% ownership of the company. This is the first filing by Palo Alto Investors LP disclosing ownership of Revance Therapeutics, Inc. Common Stock, par value $0.001 per share (RVNC).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.